Skip to main content
BioSyent Inc. logo

BioSyent Inc. — Investor Relations & Filings

Ticker · RX ISIN · CA0906901081 TSXV Manufacturing
Open in API
Filings indexed 182 across all filing types
Latest filing 2026-04-23 Annual Report
Country CA Canada
Listing TSXV RX

About BioSyent Inc.

https://www.biosyent.com/

BioSyent Inc. is a profitable, growth-oriented specialty pharmaceutical company focused on enhancing patient lives by addressing unmet medical needs. The company's primary business model involves sourcing, in-licensing, and acquiring innovative pharmaceutical and healthcare products globally for development and commercialization. BioSyent markets a diverse portfolio of products, including prescription, over-the-counter, and behind-the-counter options, primarily serving markets in Canada and select international regions.

Recent filings

Filing Released Lang Actions
Annual report - English.pdf
Annual Report Classification · 100% confidence The document is explicitly titled 'ANNUAL REPORT 2025' and contains comprehensive financial information, including audited consolidated financial statements, management's discussion and analysis (MD&A), financial highlights, and a letter from the Chairman. It covers the full fiscal year ending December 31, 2025, and provides a detailed overview of the company's performance, strategy, and governance. This fits the definition of an Annual Report (10-K). FY 2025
2026-04-23 English
Annual report - English.pdf
Annual Report Classification · 100% confidence The document is titled 'ANNUAL REPORT 2025' and contains detailed financial highlights, management discussion and analysis, audited consolidated financial statements, independent auditor's report, and notes to the financial statements for the years ended December 31, 2025 and 2024. It includes comprehensive sections such as revenue, net income, EBITDA, earnings per share, balance sheet items, dividends, product portfolio, letter from the chairman, and acquisition details. The length is substantial (15,000 characters) and the content is consistent with a full annual report covering company activity and full financial performance for the fiscal year 2025. There is no indication that this is merely an announcement or a summary; it contains substantive financial data and analysis. Therefore, the document fits the definition of an Annual Report (10-K).
2026-04-23 English
Management information circular - English.pdf
Proxy Solicitation & Information Statement Classification · 98% confidence The document is titled “Management Information Circular” and furnishes proxy solicitation materials for BioSyent Inc.’s 2026 Annual General and Special Meeting of Shareholders. It includes voting procedures, agenda items, executive compensation, corporate governance disclosures, and schedules – all hallmarks of a proxy statement (management information circular). This fits the definition of Proxy Solicitation & Information Statement (PSI).
2026-04-23 English
Notice of meeting - English.pdf
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a Notice of the 2026 Annual General and Special Meeting of Shareholders, detailing the items of business, record date, and proxy voting instructions. This is a pre‐meeting communication sent to shareholders to provide meeting information and solicit votes, matching our Proxy Solicitation & Information Statement category.
2026-04-23 English
Form of proxy - English.pdf
Proxy Solicitation & Information Statement Classification · 93% confidence The document is a Form of Proxy solicited by management for the Annual General and Special Meeting, including voting instructions, proxyholder appointments, and resolution items. This is part of proxy solicitation materials rather than the actual annual report, dividend notice, or management change announcement. It matches the definition for Proxy Solicitation & Information Statement (Proxy Form).
2026-04-23 English
Management information circular - English.pdf
Proxy Solicitation & Information Statement Classification · 95% confidence The document is titled “Management Information Circular” and contains proxy solicitation details, notice of the annual general and special meeting, voting instructions, executive compensation, and corporate governance disclosures. These are materials sent to shareholders to request votes for an upcoming meeting, matching the definition of a Proxy Solicitation & Information Statement (PSI).
2026-04-23 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.